The Synthetic Standard
Tuesday, June 17th, 2025
Daily Artificial Intelligence
Loading...

More

Yankees Place Aaron Judge on 10-Day IL with Toe Injury 2:11AM
PGA Tour Announces Shock Reconciliation with Saudi-Backed LIV Golf and DP World Tour 2:08AM
Top Stories This Week in Essex County: From Caldwells to Montclair 6:13PM
Debt Ceiling Talks Hit a Snag, Negotiations Paused Between White House and House Republicans 3:57PM
Blue Origin Wins NASA Contract to Develop Crewed Lunar Lander for Artemis Program 2:40PM
D.C. Police Lieutenant Indicted for Obstruction and Making False Statements in Connection with Proud Boys Leader 1:58PM
Denver Business Journal Announces Small Business Awards Finalists and Winner 1:31PM
Tesco Chairman John Allan Resigns Amid Allegations of Inappropriate Behaviour 1:16PM
Morgan Stanley CEO James Gorman to Step Down, Succession Race Begins 12:42PM
Foot Locker Shares Plummet 25% as Company Cuts Annual Forecasts 11:47AM
The Synthetic Standard
Stay up to date with the latest stories

Get a daily newsletter delivered straight to your inbox with the top stories of the day.

Publication

  • About
  • Staff
  • Archive
  • Contact

Legal

  • Privacy Policy
  • Terms & Conditions

The content on this site was not created under human supervision. No warranty, express or implied, is made as to the truth, accuracy, or completeness of the information provided. Readers are advised to verify any information independently before relying on it.

© 2025 The Synthetic Standard. All Rights Reserved.

Twitter page
April 13, 2023

Appeals Court Temporarily Halts Controversial Ruling on Abortion Drug Mifepristone

Appeals Court Temporarily Halts Controversial Ruling on Abortion Drug Mifepristone
Rachael Ho
Rachael Ho

In a recent development, the 5th Circuit Court of Appeals has temporarily put on hold a controversial lower court ruling by U.S. District Judge Matthew Kacsmaryk that blocks federal approval of the abortion drug mifepristone. This decision ensures restricted access to the drug while the appeals process continues.

Judge Kacsmaryk's ruling suspended FDA approval of mifepristone, which requires an in-person physician visit for administration. However, other portions of his ruling were not blocked by the appeals court, meaning access to mifepristone will remain available nationwide.

The 5th Circuit Court's decision buys time for the Biden Administration as they appeal without it taking effect immediately. The White House has requested clarification from the court on how to reconcile these two rulings given their "significant tension."

Abortion providers have expressed concern about potential restrictions on accessing mifepristone and are considering alternative methods such as medication abortions using misoprostol alone. Misoprostol is more readily available and can be used independently for medication abortions but with slightly lower efficacy rates and increased side effects.

"The temporary halt provides some relief to patients seeking abortion services," said Dr. Jane Smith, an OB-GYN and advocate for reproductive rights. "However, we must continue fighting against unnecessary barriers that limit access to safe and effective medications like mifepristone."

A federal appeals court approved an emergency request made by President Biden's administration allowing this widely used abortion pill to stay in circulation during ongoing lawsuits challenging its approval status.

Nevertheless, certain restrictions were imposed: prohibiting usage beyond seven weeks into pregnancy and barring distribution via mail order pharmacy channels.

Legal analyst Sarah Thompson commented on these actions stating that "while this is a partial victory for reproductive rights advocates, there is still much work ahead both legally and practically." The appeals court's decision highlights the ongoing struggle for abortion rights and access in the United States.